Correlation Between Vyne Therapeutics and Eyenovia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and Eyenovia, you can compare the effects of market volatilities on Vyne Therapeutics and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and Eyenovia.

Diversification Opportunities for Vyne Therapeutics and Eyenovia

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vyne and Eyenovia is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and Eyenovia go up and down completely randomly.

Pair Corralation between Vyne Therapeutics and Eyenovia

Given the investment horizon of 90 days Vyne Therapeutics is expected to generate 0.3 times more return on investment than Eyenovia. However, Vyne Therapeutics is 3.33 times less risky than Eyenovia. It trades about 0.19 of its potential returns per unit of risk. Eyenovia is currently generating about -0.24 per unit of risk. If you would invest  237.00  in Vyne Therapeutics on August 24, 2024 and sell it today you would earn a total of  53.00  from holding Vyne Therapeutics or generate 22.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vyne Therapeutics  vs.  Eyenovia

 Performance 
       Timeline  
Vyne Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vyne Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Vyne Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Vyne Therapeutics and Eyenovia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vyne Therapeutics and Eyenovia

The main advantage of trading using opposite Vyne Therapeutics and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.
The idea behind Vyne Therapeutics and Eyenovia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance